Comparing Adalimumab vs Golimumab
Adalimumab | Golimumab |
|
---|
Adalimumab | Golimumab |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Adalimumab is a TNF-alfa inhibitor that may be used to treat a wide range of different inflammatory conditions, such as rheumatoid Arthritis, psoriasis, ankylosing spondylitis, Crohn's disease, and... View more |
Prescription only
Prescribed for Psoriatic Arthritis, Ankylosing Spondylitis, Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Spondyloarthritis, Ulcerative Colitis. Golimumab may also be used for... View more |
Related suggestions Rheumatoid Arthritis
Ulcerative Colitis
Ankylosing Spondylitis
|
|||||||
More about Adalimumab | More about Golimumab | ||||||||
Ratings & Reviews | |||||||||
Adalimumab has an average rating of 6.4 out of 10 from a total of 746 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 29% reported a negative effect. |
Golimumab has an average rating of 6.2 out of 10 from a total of 157 ratings on Drugs.com. 52% of reviewers reported a positive effect, while 29% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Adalimumab side effects |
View all Golimumab side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Lower cost generic |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Adalimumab prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Humira, Hyrimoz, Idacio, Simlandi, Yuflyma, Yusimry View more | Simponi, Simponi Aria | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
480 hours |
336 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 557 drugs are known to interact with Adalimumab:
|
A total of 557 drugs are known to interact with Golimumab:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
N/A |
N/A |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.